CORGARD

This brand name is authorized in France, United Kingdom, United States

Active ingredients

The drug CORGARD contains one active pharmaceutical ingredient (API):

1 Nadolol UNII FEN504330V - NADOLOL

Nadolol is a synthetic nonselective beta-adrenergic receptor blocking agent. Clinical pharmacology studies have demonstrated beta-blocking activity by showing (1) reduction in heart rate and cardiac output at rest and on exercise, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol-induced tachycardia, and (4) reduction of reflex orthostatic tachycardia. Read about Nadolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CORGARD Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AA12	Nadolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 62092895
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161533, 36877, 381271
Country: US	FDA, National Drug Code	Identifier(s): 27505-100, 27505-101, 27505-102